Markets:

Overview

News

Currencies

International

Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

204.44 +4.44 (+2.22%)

Streaming Delayed Price Updated: 10:28 AM EDT, Apr 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Natera, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

20 21 Next >

Analyst Ratings for Natera ↗

October 16, 2023

Via Benzinga

Natera to Present New Signatera™ MRD Data at ESMO 2023, Featuring Large, Updated Analysis from CIRCULATE-Japan Study

October 16, 2023

From Natera, Inc.

Via Business Wire

NATERA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Natera, Inc. - NTRA

October 06, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

New MRD Publication in Unresectable Stage I-III Lung Cancer Demonstrates Signatera’s Ability to Risk Stratify and Detect Progression Early

October 04, 2023

From Natera, Inc.

Via Business Wire

The Latest Analyst Ratings for Natera ↗

August 08, 2023

Via Benzinga

Why Natera Stock Is Soaring Today ↗

August 04, 2023

This DNA testing leader passed the test in Q2.

Via The Motley Fool

Supreme Court Denies CareDx Request for Appeal in Patent Case with Natera

October 03, 2023

From Natera, Inc.

Via Business Wire

Natera Submits First PMA Module to the FDA for Signatera™

October 02, 2023

From Natera, Inc.

Via Business Wire

Natera Announces Senior Leadership Appointments

September 18, 2023

From Natera, Inc.

Via Business Wire

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

Natera Earnings Preview ↗

August 02, 2023

Via Benzinga

What 7 Analyst Ratings Have To Say About Natera ↗

July 21, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 ↗

September 28, 2023

Via Benzinga

Natera Announces Expanded I-SPY 2 Collaboration to Evaluate Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting

September 14, 2023

From Natera, Inc.

Via Business Wire

Natera Announces Pricing of $250 Million Follow-On Offering

September 07, 2023

From Natera, Inc.

Via Business Wire

Natera Launches Proposed Follow-On Offering

September 06, 2023

From Natera, Inc.

Via Business Wire

Natera to Participate in Upcoming Investor Conferences

September 01, 2023

From Natera, Inc.

Via Business Wire

Natera’s Prospera™ Lung Transplant Assessment Test Granted Medicare Coverage

August 16, 2023

From Natera, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 04, 2023

Via Benzinga

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 04, 2023

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Via Benzinga

Investors Cheer Jobs Report: Why Are These 5 Stocks And 5 ETFs Shining On Friday? ↗

August 04, 2023

Via Benzinga

Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗

August 04, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 03, 2023

Via Benzinga

Natera Reports Second Quarter 2023 Financial Results

August 03, 2023

From Natera, Inc.

Via Business Wire

Natera to Participate in Canaccord Genuity 43rd Annual Growth Conference

August 02, 2023

From Natera, Inc.

Via Business Wire

Natera Files Patent Infringement Suit Against NeoGenomics

July 31, 2023

From Natera, Inc.

Via Business Wire

Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera™ in Colorectal Cancer

July 28, 2023

From Natera, Inc.

Via Business Wire

Natera to Report its Second Quarter 2023 Results on August 3rd

July 27, 2023

From Natera, Inc.

Via Business Wire

Court Issues Favorable Ruling for Natera in False Advertising Trial Against CareDx; Eliminates all Damages

July 17, 2023

From Natera, Inc.

Via Business Wire

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.